NHS patients to get new Multiple Sclerosis drug Alemtuzumab

Posted: Published on May 29th, 2014

This post was added by Dr Simmons

Scientists have spent 25 years developing treatment at Cambridge Alemtuzumab infusion is given in two short courses over two years Despite costing 56,000, NICE has ruled treatment is cost-effective

By Jenny Hope

Published: 19:16 EST, 27 May 2014 | Updated: 07:13 EST, 28 May 2014

4,912 shares

45

View comments

Landmark discovery: The brain of someone with MS, which can leave sufferers unable to walk - but new treatment could reverse the effects of the disease

A new treatment for Multiple Sclerosis not only stops the disease from advancing but may help patients recover from disability.

Remarkable results for the drug alemtuzumab mean it has been approved for use on the NHS and is now available in England.

Originally a pioneering cancer therapy, Cambridge University scientists have spent almost 25 years developing it as a treatment for MS sufferers.

Read more:
NHS patients to get new Multiple Sclerosis drug Alemtuzumab

Related Posts
This entry was posted in MS Treatment. Bookmark the permalink.

Comments are closed.